ClinicalTrials.gg
DrugBiological

Regramostim clinical trials

Also written rhGM-CSF.

studies test it
13
open now
0
in phase 3
1
first study started
2005

How each study uses regramostim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Topleucon®
2

Development codes

rhGM-CSF
7

In one entry with another drug

Given together, or one or the other

pTVG-HP with rhGM-CSF
2

Studies by the year they started

13 studies that test it; most in 2009 (2)

Studies that test regramostim, by start year
YearStudies
20051
20092
20101
20121
20131
20151
20161
20171
20181
20191
20212

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
8
Phase 3
1
Phase 4
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 8

Savara Inc. (2) · University of Wisconsin, Madison (2) · Peking University Cancer Hospital & Institute (1) · Xiamen Amoytop Biotech Co., Ltd. (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Reponex Pharmaceuticals A/S (1) · Shandong Cancer Hospital and Institute (1) · The Affiliated Hospital of the Chinese Academy of Military Medical Sciences (1)

Often tested with

Tested in the same studies.

Ptvg-hp (2) · Molgramostim (1)

Studies

Open first, then newest update. How each study uses regramostim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Given beside what is tested · 1 — regramostim is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with regramostim

Codes

What other systems call regramostim · ClinicalTrials.gg INT017088

  • UNII (FDA) KR89Q40F01REGRAMOSTIMOne source FDA
  • NCI Thesaurus C170366RegramostimOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.